Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment - Does that matter?

Radiother Oncol. 2016 Jan;118(1):211-3. doi: 10.1016/j.radonc.2016.02.001.

¹ Dept. of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; German Cancer Research Center (DKFZ) Heidelberg, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Germany; National Center for Tumor Diseases (NCT), partner site Dresden, Germany.
² Dept. of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; German Cancer Research Center (DKFZ) Heidelberg, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Germany; National Center for Tumor Diseases (NCT), partner site Dresden, Germany. Electronic address: Mechthild.krause@uniklinikum-dresden.de.

No abstract available

Publication types